Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: Trade Data, Destination Markets, and Economic Impact
Priya Life Science Clinical trial register
TrackersDrugsComparisonsAPI
Trackers› Clinical trials› Göttingen
Clinical trial register · Germany

Clinical Trials in Göttingen, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Germany and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 5062 matching records held by the registry are in this view. Synced 20 Oct 2026, 03:18 UTC
5062
Studies in scope
all four open statuses
2873
Recruiting now
open to new participants
988
Lead sponsors
across recruiting studies
Top sites
Berlin 1586 Hamburg 889 Essen 766 Dresden 716 Heidelberg 627
Narrow the registerReset
Recruitment status
Phase
Lead sponsor
University Medical Center Goettingen19 AstraZeneca12 argenx8 Novartis Pharmaceuticals7 Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest7
Site location
Berlin1586 Hamburg889 Essen766 Dresden716 Heidelberg627
All 639 locations
Target enrolment
to

Trials with a site in Göttingen

200 of 5062 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Germany
Start
Not yet open
University Medical Center Goettingen
Not applicable
144
Göttingen
2028-01
Not yet open
Chiesi Farmaceutici S.p.A.
Phase 3
700
Frankfurt, Göttingen, Jena, Stuttgart
2026-11-16
Recruiting
Orofacial Pain and Oral Health-Related Quality of Life in Musicians in German Amateur Orchestras
NCT07714837Orofacial Pain, Sleep Bruxism, Oral Health Related Quality of Life (OHRQoL)
University Medical Center Goettingen
Observational
400
Göttingen
2026-09-01
Recruiting
AstraZeneca
Phase 3
1,500
Berlin, Bochum, Bünde, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg
2026-08-20
Recruiting
AstraZeneca
Phase 3
2,500
Berlin, Bochum, Bünde, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg
2026-08-19
Not yet open
D-TECT: Pretreatment D-dimers and Disease Control in Advanced cSCC Treated With Cemiplimab
NCT07684066Cutaneous Squamous Cell Carcinoma (CSCC), Advanced Cutaneous Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma
Universitätsklinikum Hamburg-Eppendorf
Observational
116
Bielefeld, Bremerhaven, Buxtehude, Erlangen, Göttingen, Hamburg, Hanover, Kiel
2026-08-01
Not yet open
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
101
Berlin, Cologne, Essen, Frankfurt am Main, Göttingen, Halle, Hamburg, Heidelberg
2026-07-01
Recruiting
Alianza multidisciplinar para la investigación de los tumores genitourinarios -GUARD
Phase 3
320
Berlin, Bonn, Gera, Göttingen, Halle, Karlsruhe, Recklinghausen, Rostock
2026-06-05
Recruiting
Takeda
Phase 2
222
Heidelberg, Tübingen, Potsdam, Frankfurt am Main, Göttingen, Dresden, Berlin
2026-05-17
Recruiting
Efficacy, Safety, and Tolerability of Zeleciment Basivarsen (DYNE-101) in Participants With Myotonic Dystrophy Type 1
NCT07486934Myotonic Dystrophy Type 1 (DM1), DM1, Myotonic Dystrophy, Steinert Disease
DrugZeleciment basivarsen
Dyne Therapeutics
Phase 3
150
Munich, Göttingen, Bonn, Berlin
2026-05-14
Recruiting
Oral Health in Palliative Care: A Survey Study
NCT07324525Oral Health Care, Oral Health-Related Quality of Life, Palliative Care, Palliative Care, Patient Care
University Medical Center Goettingen
Observational
151
Göttingen
2026-02-24
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
80
Berlin, Bielefeld, Dresden, Essen, Frankfurt, Göttingen, Hamburg, Herne
2026-01-16
Recruiting
Celldex Therapeutics
Phase 3
240
Augsburg, Berlin, Buxtehude, Darmstadt, Dresden, Düsseldorf, Erlangen, Göttingen
2026-01-15
Recruiting
University Hospital, Grenoble
Observational
1,600
Bayreuth, Göttingen, Jena, Mannheim, Ulm
2026-01-15
Recruiting
Improving Dental Care for Patients With Head and Neck Tumors
NCT07328347Oral Health Care, Oral Health Behavior Change, Head & Neck Cancer, Dentist's Role
University Medical Center Goettingen
Not applicable
134
Göttingen
2026-01-13
Recruiting
German Center for Neurodegenerative Diseases (DZNE)
Not applicable
554
Karlsruhe, Konstanz, Reutlingen, Darmstadt, Hanover, Göttingen, Greifswald, Rostock
2026-01-01
Recruiting
argenx
Phase 2
70
Berlin, Göttingen, Würzburg
2025-12-19
Recruiting
argenx
Observational
70
Berlin, Göttingen, Würzburg
2025-12-19
Recruiting
Blueprint Medicines Corporation
Observational
80
Berlin, Bochum, Deggendorf, Dresden, Freiburg im Breisgau, Göttingen, Leipzig, Munich
2025-12-09
Recruiting
Christian Schulze
Phase 3
536
Jena, Bad Nauheim, Berlin, Bonn, Dresden, Göttingen, Halle, Leipzig
2025-12-08
Recruiting
Screening for Supportive Care Needs of Oncological Patients and Professionals - Evaluation of a Short PRO-question Set
NCT07505498Patient Related Outcome Measures, Supportive Care, Patient Reported Outcome (PRO)
University Medical Center Goettingen
Observational
900
Göttingen
2025-12-01
By invitation
FINancial Toxicity and CAncer REcovery in YOUNG Adults
NCT07314801Financial Toxicity Related to Cancer Diagnosis and Tretment in Adolescents and Young Adults
University Medical Center Goettingen
Observational
300
Göttingen
2025-12
Recruiting
Hoffmann-La Roche
Phase 3
250
Chemnitz, Düsseldorf, Göttingen, Hanover, Rostock, Würzburg
2025-11-27
Recruiting
Alexion Pharmaceuticals, Inc.
Phase 2
75
Berlin, Essen, Göttingen, Ludwigshafen, München
2025-11-26
Recruiting
Merck Sharp & Dohme LLC
Phase 3
904
Stuttgart, Tübingen, Göttingen, Schwerin, Herne, Münster, Dresden, Erfurt
2025-11-26
Active, closed
Bayer
Phase 2
60
Erlangen, Göttingen, Cologne, Berlin
2025-11-19
Recruiting
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
40
Aachen, Bonn, Essen, Frankfurt, Giessen, Göttingen, Hamburg, Jena
2025-11-18
Recruiting
UCB Biopharma SRL
Phase 3
320
Ahaus, Bad Bentheim, Berlin, Bielefeld, Bochum, Dresden, Göttingen, Kiel
2025-11-14
Recruiting
Juno Therapeutics, Inc., a Bristol-Myers Squibb Company
Phase 2
65
Freiburg im Breisgau, Ulm, Cologne, Essen, Chemnitz, Berlin, Göttingen, Hamburg
2025-11-06
Recruiting
AbbVie
Phase 3
561
Freiburg im Breisgau, Tübingen, Ulm, Munich, Göttingen, Hanover, Bonn, Ludwigshafen am Rhein
2025-11-05
Active, closed
Bristol-Myers Squibb
Phase 2/3
470
München, Frankfurt am Main, Göttingen, Bochum, Chemnitz, Dresden, Berlin, Cologne
2025-10-23
Recruiting
Imbria Pharmaceuticals, Inc.
Phase 2
165
Bad Oeynhausen, Göttingen, Heidelberg, Jena
2025-10-06
Not yet open
Medical University Innsbruck
Not applicable
80
Berlin, Freiburg im Breisgau, Göttingen, München, Münster, Tübingen
2025-09-30
Recruiting
Pfizer
Phase 3
1,000
Heidelberg, Nürtingen, Ulm, Göttingen, Mettmann, Lübeck, Berlin, Düsseldorf
2025-09-28
Recruiting
LEO Pharma
Phase 2
135
Bad Bentheim, Dresden, Göttingen, Hamburg, Kiel, Lübeck, Manheim, Münster
2025-09-11
Not yet open
Federation Francophone de Cancerologie Digestive
Phase 2
300
Bochum, Frankfurt, Göttingen, Hamburg
2025-08-31
By invitation
University Medical Center Goettingen
Not applicable
22
Göttingen
2025-08-27
Recruiting
NSC-Therapeutics
Phase 1/2
90
Altenburg, Bad Homburg, Cologne, Göttingen, Mannheim, Ratingen
2025-08-25
Recruiting
Technical University of Munich
Not applicable
322
Munich, Frankfurt am Main, Berlin, Aachen, Cologne, Dresden, Essen, Göttingen
2025-08-13
Recruiting
Real-World Efgartigimod Effectiveness in CIDP: A Prospective Study
NCT07264426Chronic Inflammatory Demyelinating Polyradiculoneuropathy, CIDP, CIDP (Chronic Inflammatory Demyelinating Polyradiculoneuropathy)
DrugEfgartigimod PH20
argenx
Observational
200
Berlin, Bochum, Cologne, Düsseldorf, Frankfurt, Giessen, Göttingen, Hamburg
2025-08-11
Recruiting
Preoperative Stereotactic Radiotherapy for Treatment of Spinal Metastases
NCT07135817Spinal Metastases, Solid Tumor Cancer
University Medical Center Goettingen
Not applicable
20
Göttingen
2025-08-01
Recruiting
Celgene
Phase 3
400
Ulm, Augsburg, Göttingen, Dortmund, Düsseldorf, Münster, Homburg, Erfurt
2025-07-28
Recruiting
Pharmazz, Inc.
Phase 3
514
Altenburg, Göttingen, Rhein, Minden, Recklinghausen, Berlin, Bad Neustadt an der Saale, Erlangen
2025-07-24
Recruiting
Bristol-Myers Squibb
Phase 3
586
Munich, Göttingen, Bad Homburg, Chemnitz, Cologne, Ulm
2025-07-21
Active, closed
Bluefin Biomedicine, Inc.
Phase 2
225
Bad Bentheim, Berlin, Göttingen, Heidelberg, Münster
2025-07-15
Recruiting
Alnylam Pharmaceuticals
Phase 3
1,750
Berlin, Cologne, Dresden, Göttingen, Hanover, Heidelberg, Leipzig, Magdeburg
2025-07-02
Recruiting
AGO Research GmbH
Phase 2
42
Augsburg, Bad Homburg, Dresden, Düsseldorf, Essen, Göttingen, Hamburg, Hanau
2025-06-24
Active, closed
Novartis Pharmaceuticals
Phase 1/2
27
Freiburg im Breisgau, Göttingen, Cologne, Berlin, Ulm
2025-06-20
Active, closed
Incyte Corporation
Phase 3
159
Bad Bentheim, Bonn, Chemnitz, Dresden, Frankfurt, Göttingen, Kiel, Mainz
2025-06-17
Active, closed
Incyte Corporation
Phase 3
573
Bad Bentheim, Göttingen, Hanover, Kiel, Langenau, Merzig
2025-06-12
Recruiting
A Study to Evaluate Del-brax (Also Referred to as AOC 1020) in Participants With FSHD
NCT07038200Facioscapulohumeral Muscular Dystrophy, FSHD, FSHD - Facioscapulohumeral Muscular Dystrophy, FSHD1
DrugDel-brax
Avidity Biosciences, Inc.
Phase 3
200
Bonn, Göttingen, München, Ulm
2025-06-10
Active, closed
Incyte Corporation
Phase 3
9
Aachen, Berlin, Cologne, Dresden, Erlangen, Frankfurt am Main, Freiburg im Breisgau, Göttingen
2025-06-04
Recruiting
University Hospital Goettingen
Observational
20
Göttingen
2025-05-01
Recruiting
InsightRP2 Registry
NCT06982417RP2-associated Retinitis Pigmentosa, X-Linked Retinitis Pigmentosa (XLRP), Retinitis Pigmentosa 2
University of Göttingen
Observational
200
Göttingen
2025-05-01
By invitation
Long-term Safety and Efficacy Study of Riliprubart in Participants With CIDP
NCT06859099Polyneuropathy, Inflammatory Demyelinating, Chronic
DrugRiliprubart
Sanofi
Phase 3
300
Göttingen, Münster, Tübingen
2025-04-01
Recruiting
A Multi-omic Approach to the Identification of Novel Biomarkers in Early Charcot-Marie-Tooth 1A Disease (CMT1A)
NCT07476365CMT, CMT (Charcot Marie Tooth Disease), CMT - Charcot-Marie-Tooth Disease, CMT1A
University Medical Center Goettingen
Observational
70
Göttingen
2025-03-24
By invitation
University Medical Center Goettingen
Observational
130
Göttingen
2025-03-01
Recruiting
Karsten Gavenis
Observational
170
Göttingen, Hanover, Oldenburg
2025-02-24
Recruiting
Central Institute of Mental Health, Mannheim
Not applicable
140
Aachen, Augsburg, Göppingen, Göttingen, Hanover, Heidelberg, Ingolstadt, Mainz
2025-02-14
Active, closed
Viridian Therapeutics, Inc.
Phase 3
320
Berlin, Essen, Göttingen, Mainz
2025-02-03
Recruiting
FORTIFI-HN01: A Study of Ficerafusp Alfa (BCA101) or Placebo in Combination With Pembrolizumab in First-Line PD-L1-pos, R or M HNSCC
NCT06788990Metastatic Head and Neck Squamous Cell Carcinoma, Recurrent Head and Neck Squamous Cell Carcinoma
DrugsFicerafusp alfa·Keytruda·Pembrolizumab
Bicara Therapeutics
Phase 2/3
650
Aachen, Berlin, Braunschweig, Chemnitz, Dresden, Düsseldorf, Essen, Göttingen
2025-01-28
Recruiting
Colorectal Resections in Patients With Retroperitoneal Sarcoma
NCT06943612Sarcoma, Soft Tissue, Retroperitoneal Sarcoma
Heidelberg University
Observational
120
Mannheim, Göttingen, Berlin, Cologne, Dresden, Erlangen, Greifswald, Halle
2025-01-27
Recruiting
Lumbar Drainage of Intraventricular Hemorrhage
NCT06510842Intraventricular Hemorrhage, Lumbar Drainage, External Ventricular Drainage
University Hospital Heidelberg
Not applicable
354
Heidelberg, München, Augsburg, Berlin, Düsseldorf, Frankfurt, Göttingen, Mainz
2025-01-16
Recruiting
Loxo Oncology, Inc.
Phase 2
249
Cologne, Frankfurt, Göttingen, Hanover, Hösbach, Koblenz
2025-01-03
Recruiting
Santen SAS
Phase 3
234
Goettigen, Göttingen
2024-12-30
Active, closed
argenx
Phase 3
154
Essen, Göttingen, Lübeck, Münster, Potsdam, Würzburg
2024-12-18
By invitation
Phase 1b Long-term Extension Trial of RAY121 in Immunological Diseases (RAINBOW-LTE Trial)
NCT06723106Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Tübingen, Erlangen, Sachsen, Göttingen, Lübeck
2024-12-09
Recruiting
University Hospital Freiburg
Not applicable
20,000
Berlin, Freiburg im Breisgau, Göttingen
2024-12-03
Recruiting
Institut de Recherches Internationales Servier
Phase 3
48
Dresden, Düsseldorf, Göttingen, Leipzig, Munich
2024-12-03
Active, closed
Genmab
Phase 3
191
Esslingen am Neckar, Heidelberg, Göttingen, Hanover, Mainz, Dresden, Halle, Großhansdorf
2024-11-25
Active, closed
Regeneron Pharmaceuticals
Phase 2
120
Kassel, Göttingen, Leipzig, Aachen
2024-11-18
Recruiting
Longitudinal Biomarkers With Selected Outcome Measures In CMT
NCT06794489CMT1A, CMT (Charcot Marie Tooth Disease), CMT 1A, CMT - Charcot-Marie-Tooth Disease
University Medical Center Goettingen
Observational
75
Göttingen
2024-11-06
Recruiting
argenx
Observational
680
Altenburg, Bochum, Göppingen, Göttingen, Gummersbach, Jena, Würzburg
2024-11-04
Recruiting
Regeneron Pharmaceuticals
Phase 3
975
Ulm, Berlin, Frankfurt am Main, Marburg, Göttingen, Neubrandenburg, Bonn, Düsseldorf
2024-10-30
Active, closed
Novartis Pharmaceuticals
Phase 2
96
Freiburg im Breisgau, Göttingen, Leipzig, Halle, Jena, Berlin, Lübeck, Mainz
2024-10-29
Active, closed
Incyte Corporation
Phase 3
346
Aachen, Buxtehude, Chemnitz, Darmstadt, Dresden, Frankfurt am Main, Göttingen, Magdeburg
2024-10-10
Recruiting
Janssen Research & Development, LLC
Phase 2/3
274
Bonn, Göttingen, Hanover, Leipzig, Ludwigshafen am Rhein, Münster, Tübingen
2024-09-19
Active, closed
argenx
Phase 3
141
Berlin, Göttingen
2024-09-18
Recruiting
AstraZeneca
Phase 1/2
174
Göttingen, München, Ulm, Würzburg
2024-09-18
Active, closed
Novo Nordisk A/S
Phase 4
500
Bochum, Göttingen, Hanover, Leipzig, Ulm
2024-09-17
Active, closed
Viridian Therapeutics, Inc.
Phase 3
204
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Active, closed
Viridian Therapeutics, Inc.
Phase 3
132
Berlin, Dresden, Giessen, Göttingen
2024-08-27
Recruiting
Durvalumab + Intraductal Radiofrequency Ablation (ID-RFA) in Extrahepatic Cholangiocarcinoma
NCT06440993Extrahepatic Cholangiocarcinoma, Unresectable Perihilar or Ductal CCA
DrugsDurvalumab·Gemcitabine·Cisplatin
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
42
Aachen, Bonn, Cologne, Düsseldorf, Frankfurt, Göttingen, Hanover, Lübeck
2024-08-23
Recruiting
Sanofi
Phase 3
160
Berlin, Bochum, Bremen, Essen, Göttingen, Hanover, Homburg, Münster
2024-08-21
Recruiting
Phase 1b Trial of RAY121 in Immunological Diseases (RAINBOW Trial)
NCT06371417Antiphospholipid Syndrome (APS), Bullous Pemphigoid (BP), Behçet's Syndrome (BS), Dermatomyositis (DM)
DrugRAY121
Chugai Pharmaceutical
Phase 1
144
Tübingen, Erlangen, Rüdersdorf, Sachsen, Göttingen, Lübeck
2024-08-19
Recruiting
CABP2 Patient Registry and Natural History Study
NCT06680934CABP2-related Auditory Synaptopathy, Hearing Impairment
University Medical Center Goettingen
Observational
100
Göttingen
2024-08-16
Recruiting
AstraZeneca
Phase 3
620
Berlin, Bonn, Cologne, Dresden, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg
2024-08-12
Recruiting
AstraZeneca
Phase 3
1,018
Berlin, Deggendorf, Düsseldorf, Göttingen, Hamburg, Heidelberg, Jena, Karlsruhe
2024-08-07
Recruiting
AstraZeneca
Phase 3
788
Aachen, Augsburg, Berlin, Cologne, Dessau, Düsseldorf, Erlangen, Göttingen
2024-08-01
By invitation
University Hospital Goettingen
Observational
100
Göttingen
2024-08
Recruiting
TREMOR IN CHARCOT-MARIE-TOOTH
NCT07570459CMT, CMT (Charcot Marie Tooth Disease), Charcot Marie Tooth Disease (CMT), Charcot Marie Tooth Disease
University Medical Center Goettingen
Observational
75
Göttingen
2024-07-30
Recruiting
AUTONOMOUS DISORDERS IN CMT
NCT07570446CMT - Charcot-Marie-Tooth Disease, CMT1A, CMT (Charcot Marie Tooth Disease)
University Medical Center Goettingen
Observational
50
Göttingen
2024-07-30
Recruiting
Hannover Medical School
Not applicable
756
Ludwigsburg, Tübingen, Bad Homburg, Göttingen, Hanover, Lüneburg, Bielefeld, Düsseldorf
2024-07-17
Recruiting
Heidelberg University
Observational
4,000
Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen, Heidelberg, Kiel
2024-07-16
Active, closed
Ultra-high-caloric, Fatty Diet in ALS
NCT06280079Amyotrophic Lateral Sclerosis
University of Ulm
Not applicable
399
Aachen, Berlin, Bochum, Bonn, Dresden, Erlangen, Essen, Göttingen
2024-07-02
Recruiting
PACCELIO - FDG-PET Based Small Volume Accelerated Immuno Chemoradiotherapy in Locally Advanced NSCLC
NCT06102057Stage III Non-small Cell Lung Cancer, Locally Advanced, Unresectable
TheraOp
Phase 2
110
Dresden, Essen, Freiburg im Breisgau, Göttingen, Homburg, Mönchengladbach, München, Oldenburg
2024-07-01
Recruiting
Merck Healthcare KGaA, Darmstadt, Germany, an affiliate of Merck KGaA, Darmstadt, Germany
Phase 3
264
Ulm, Göttingen, Hanover, Bochum, Düsseldorf, Dresden, Leipzig, Lübeck
2024-06-25
Recruiting
Molecular Mechanisms in Malignant Lymphoma- Predict (MMML Predict)
NCT06526065DLBCL - Diffuse Large B Cell Lymphoma
University Medical Center Goettingen
Observational
500
Göttingen
2024-06-20
Recruiting
Long-Term Follow-up of Patients Treated With Miltenyi Cell and Gene Therapies
NCT06508775Melanoma Stage III, B-cell Non Hodgkin Lymphoma, Pediatric ALL, Childhood Non-Hodgkin Lymphoma
DrugsMB-CART19.1·Zamtocabtagene autoleucel
Miltenyi Biomedicine GmbH
Not applicable
40
Berlin, Cologne, Erlangen, Göttingen, Münster, Tübingen, Würzburg
2024-05-05
Active, closed
Merck Sharp & Dohme LLC
Phase 3
450
Heidelberg, Göttingen, Dresden, Kiel, Berlin, Hamburg
2024-05-03
Recruiting
Insel Gruppe AG, University Hospital Bern
Not applicable
482
Lübeck, Berlin, Bonn, Göttingen, Hamburg, Heidelberg, Leipzig, Mannheim
2024-05-01
Recruiting
Pancreatitis - Microbiome as Predictor of Severity II
NCT06508502Acute Pancreatitis, Acute Pancreatitis With Infected Necrosis
University Medical Center Goettingen
Observational
700
Göttingen
2024-05-01
Recruiting
AstraZeneca
Phase 3
582
Berlin, Cologne, Erfurt, Frankfurt, Göttingen, Immenhausen, Kiel, Mainz
2024-04-29
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
24
Augsburg, Berlin, Frankfurt, Freiburg im Breisgau, Göttingen, Hamburg, Hanover, München
2024-04-17
Active, closed
Janssen-Cilag Ltd.
Phase 3
120
Augsburg, Berlin, Dachau, Frankfurt, Göttingen, Halle, Hanover, Kiel
2024-04-17
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
24
Göttingen
2024-04-10
Recruiting
Marc Bosiers, MD
Observational
109
Berlin, Frankfurt, Göttingen, Heidelberg, Lünen, Münster, Regensburg, Stuttgart
2024-04-05
Recruiting
University Hospital Goettingen
Phase 3
102
Heidelberg, München, Hamburg, Frankfurt am Main, Göttingen, Cologne, Münster, Leipzig
2024-03-25
Recruiting
Technische Universität Dresden
Observational
500
Aachen, Chemnitz, Dresden, Düsseldorf, Essen, Göttingen, Hamburg, Jena
2024-03-13
Active, closed
AstraZeneca
Phase 3
594
Berlin, Frankfurt, Göttingen, Hamburg, Heidelberg, Heilbronn, Leipzig, Marburg
2024-03-04
Recruiting
Arterial Stiffening as a Predictor for Diastolic Cardiac Dysfunction and HFpEF
NCT06208007Heart Failure With Preserved Ejection Fraction, Cardiovascular Morbidity
University Medical Center Goettingen
Observational
150
Göttingen
2024-02-23
Active, closed
Study Evaluating Tarlatamab After Chemoradiotherapy in Limited-Stage Small-Cell Lung Cancer (LS-SCLC)
NCT06117774Limited Stage Small Cell Lung Cancer, Small Cell Lung Cancer
DrugTarlatamab
Amgen
Phase 3
404
Essen, Göttingen, Würzburg
2024-02-20
Recruiting
Intravenous Fish Oil Based Lipid Emulsion to Enhance Recovery in High-Risk Cardiac Surgery Patients
NCT06279793Intensive Care Unit, Coronary Artery Bypass Grafting (CABG), High Risk Patients, Cardiopulmonary Bypass
GCP-Service International West GmbH
Phase 2
550
Augsburg, Berlin, Bonn, Göttingen, Hamburg, Kiel, Mainz, Münster
2024-02-15
Active, closed
Ionis Pharmaceuticals, Inc.
Phase 1/2
85
Göttingen
2024-01-04
Recruiting
Pelvic Cancer Registry for Online Adapted Radiotherapy
NCT06185062Pelvic Tumor, Thoracic Tumor
University Medical Center Goettingen
Observational
846
Göttingen
2024-01-01
Recruiting
RESET-Myositis: An Open-Label Study to Evaluate the Safety and Efficacy of CABA-201 in Subjects With Active Idiopathic Inflammatory Myopathy or Juvenile Idiopathic Inflammatory Myopathy
NCT06154252Idiopathic Inflammatory Myopathy, Dermatomyositis, Anti-Synthetase Syndrome, Immune-Mediated Necrotizing Myopathy
Cabaletta Bio
Phase 2/3
74
Göttingen
2023-12-20
Recruiting
Merck Sharp & Dohme LLC
Phase 3
1,314
Freiburg im Breisgau, Heidelberg, Nürtingen, Munich, Regensburg, Marburg, Göttingen, Bergisch Gladbach
2023-12-18
Recruiting
The NODE-202 Study (Study of Etripamil Nasal Spray in Pediatric Patients)
NCT05763953Paroxysmal Supraventricular Tachycardia
Milestone Pharmaceuticals Inc.
Phase 2
60
Göttingen
2023-12-11
Active, closed
Novartis Pharmaceuticals
Phase 3
362
Göttingen, Stade, Dresden, Berlin, Mainz, Münster, Tübingen
2023-12-07
Recruiting
Amgen
Phase 3
750
Chemnitz, Gauting, Göttingen, Kempten, München
2023-11-16
Active, closed
Novartis Pharmaceuticals
Phase 3
470
Freiburg im Breisgau, Munich, Hamburg, Göttingen, Stade, Dresden, Leipzig, Halle
2023-11-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
556
Freiburg, Göttingen, Essen, Chemnitz, Dresden, Hamburg
2023-11-12
Recruiting
Exercise CMR in (p)LF-LG AS
NCT06129799Aortic Stenosis, Severe
University of Göttingen
Observational
100
Göttingen
2023-11-01
Active, closed
Acrotech Biopharma Inc.
Phase 3
504
Göttingen, Halle
2023-10-04
Active, closed
Avacostar - (PASS)
NCT05897684ANCA-associated Vasculitis
Vifor Fresenius Medical Care Renal Pharma
Observational
507
Berlin, Cologne, Dresden, Essen, Freiburg im Breisgau, Göttingen, Hamburg, Hanover
2023-09-11
Active, closed
Cytokinetics
Phase 3
500
Berlin, Göttingen, Heidelberg, Jena
2023-08-31
Recruiting
NovoCure Ltd.
Observational
198
Gauting, Regensburg, Harburg, Bremen, Göttingen, Dresden, Berlin, Cologne
2023-08-01
Active, closed
Merck Sharp & Dohme LLC
Phase 3
1,089
Mannheim, Augsburg, München, Göttingen, Rostock, Cologne, Essen, Minden
2023-07-19
Recruiting
Hoffmann-La Roche
Phase 3
420
Aachen, Bielefeld, Essen, Freiburg im Breisgau, Georgsmarienhütte, Göttingen, Hamburg, Hanover
2023-06-07
Active, closed
Bayer
Phase 3
985
Mannheim, Nürtingen, Stuttgart, Würzburg, Frankfurt am Main, Braunschweig, Göttingen, Aachen
2023-04-03
Active, closed
Boston Scientific Corporation
Observational
1,173
Aachen, Dresden, Göttingen, Hamburg, Heidelberg, Karlsruhe, Münster
2023-03-24
Active, closed
argenx
Phase 2
51
Essen, Göttingen
2023-01-18
Active, closed
Novartis Pharmaceuticals
Phase 3
696
Munich, Marburg, Bramsche, Göttingen, Merzig, Dresden, Leipzig, Halle
2022-12-09
Active, closed
RESPONDER-HF Trial
NCT05425459Heart Failure, Heart Failure, Diastolic
Corvia Medical
Not applicable
750
Bad Krozingen, Bad Nauheim, Berlin, Cologne, Dresden, Düsseldorf, Freiburg im Breisgau, Göttingen
2022-11-17
Recruiting
Ionis Pharmaceuticals, Inc.
Observational
32
Göttingen
2022-10-03
Active, closed
Kite, A Gilead Company
Phase 3
231
Göttingen, Würzburg
2022-09-22
Active, closed
Genmab
Phase 3
549
Tübingen, Würzburg, Giessen, Kassel, Göttingen, Bonn, Dresden, Leipzig
2022-09-20
Active, closed
Biogen
Phase 2
416
Mannheim, Tübingen, Ulm, Bayreuth, München, Erbach im Odenwald, Göttingen, Bonn
2022-08-24
Recruiting
Ionis Pharmaceuticals, Inc.
Phase 1
40
Ulm, Düsseldorf, Göttingen, Hanover, Marburg, München
2022-07-21
Recruiting
Early Stage Follicular LymphOma and RadioTherapy PLUS Anti-CD20 Antibody
NCT05045664Early Stage Follicular Lymphoma WHO Grade 1/2 or 3a
Heidelberg University
Phase 3
100
Berlin, Essen, Göttingen, Heidelberg, Mönchengladbach, Munich, Regensburg, Rostock
2022-07-06
Recruiting
CytOSorb TreatMent Of Critically Ill PatientS Registry
NCT05146336Septic Shock, Acute Respiratory Distress Syndrome, Trauma, Rhabdomyolysis
CytoSorbents, Inc
Observational
3,000
Aachen, Bad Oeynhausen, Bochum, Essen, Göttingen, Herford, Jena, Kassel
2022-06-22
Active, closed
Genentech, Inc.
Observational
400
Bonn, Freiburg im Breisgau, Göttingen, Hanover, Leipzig, Münster, Tübingen
2022-05-27
Recruiting
MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
NCT05487612Coronary Artery Disease, Aortic Valve Stenosis, Extracorporeal Circulation; Complications
Aristotle University Of Thessaloniki
Not applicable
1,300
Coswig, Göttingen, Ulm
2022-05-26
Active, closed
AstraZeneca
Phase 3
760
Bonn, Chemnitz, Dresden, Düsseldorf, Frankfurt, Göttingen, Hamburg, Hanover
2022-03-28
Active, closed
UCB Biopharma SRL
Phase 3
113
Göttingen, Münster
2022-02-02
Active, closed
ADH1 and ADH2 Disease Monitoring Study (DMS)
NCT05227287Autosomal Dominant Hypocalcemia
Calcilytix Therapeutics, Inc., a BridgeBio company
Observational
95
Göttingen
2022-01-20
Active, closed
University Hospital, Basel, Switzerland
Not applicable
543
Aachen, Berlin, Bremen, Dresden, Erfurt, Frankfurt, Göttingen, Hamburg
2021-12-09
Recruiting
Goethe University
Phase 2
50
Berlin, Cologne, Dresden, Essen, Frankfurt, Gauting, Georgsmarienhütte, Göttingen
2021-11-12
Active, closed
University Eye Hospital, Freiburg
Phase 2/3
302
Ahaus, Bonn, Cologne, Erlangen, Essen, Freiburg im Breisgau, Göttingen, Hamburg
2021-10-19
Active, closed
Novartis Pharmaceuticals
Phase 3
129
Freiburg im Breisgau, Göttingen, Bochum
2021-10-05
Active, closed
Hoffmann-La Roche
Phase 1
119
Dresden, Göttingen, München, Münster, Tübingen, Ulm
2021-08-11
Active, closed
Biogen
Phase 3
562
Göttingen, Hanover, Cologne, Münster, Mainz
2021-07-16
Recruiting
Janssen Research & Development, LLC
Phase 3
199
Berlin, Göttingen, Leipzig, Lübeck, Ulm, Wiesbaden
2021-07-15
Active, closed
Britannia Pharmaceuticals Ltd.
Observational
312
Bad Segeberg, Beelitz-Heilstätten, Berlin, Cologne, Coppenbrügge, Essen, Freiburg im Breisgau, Göttingen
2021-07-06
Active, closed
AstraZeneca
Observational
752
Böblingen, Göttingen, Nürtingen, Osnabrück, Rotenburg (Wümme), Aachen, Amberg, Aschaffenburg
2021-06-15
Active, closed
Pfizer
Phase 3
599
Göttingen, Wesel, Jena, Berlin, Duisburg, Frankfurt, Heidelberg, Leipzig
2021-05-12
Active, closed
Incyte Corporation
Phase 3
899
Aachen, Augsburg, Berlin, Bonn, Chemnitz, Cottbus, Göttingen, Halle
2021-05-11
Recruiting
A Pilot Study of Larotrectinib for Newly-Diagnosed High-Grade Glioma With NTRK Fusion
NCT04655404High Grade Glioma, Diffuse Intrinsic Pontine Glioma
DrugLarotrectinib
Nationwide Children's Hospital
Early Phase 1
15
Heidelberg, Augsburg, Berlin, Cologne, Göttingen
2021-04-08
Active, closed
Hoffmann-La Roche
Phase 2
920
Essen, Göttingen, Heilbronn, Mönchengladbach
2021-01-18
Active, closed
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Phase 2
55
Bonn, Cologne, Essen, Göttingen, Hanover, Jena, Lübeck, München
2020-12-15
Active, closed
Hoffmann-La Roche
Phase 3
992
Berlin, Chemnitz, Dresden, Essen, Georgsmarienhütte, Göttingen, Hamburg, Hanover
2020-10-09
Active, closed
argenx
Phase 2
229
Bochum, Cologne, Essen, Göttingen, Kiel, Potsdam
2020-09-18
Active, closed
Krankenhaus Nordwest
Phase 3
127
Frankfurt am Main, Göttingen, Leipzig, Stuttgart
2020-07-15
Active, closed
Merck Sharp & Dohme LLC
Phase 3
870
Göttingen, Minden, Münster, Neuss, Großhansdorf, Bad Berka, Jena, Berlin
2020-07-06
Active, closed
Astellas Pharma Global Development, Inc.
Phase 3
886
Berlin, Bielefeld, Düsseldorf, Erlangen, Essen, Frankfurt am Main, Göttingen, Heidelberg
2020-03-30
Active, closed
Eli Lilly and Company
Phase 3
261
Heidelberg, Gauting, Immenstadt im Allgäu, Georgsmarienhütte, Göttingen, Cologne, Großhansdorf, Berlin
2020-02-17
Recruiting
University Medical Center Goettingen
Phase 1/2
53
Göttingen, Bad Oeynhausen, Lübeck
2020-02-03
Active, closed
CMR-AI and Outcomes in AS
NCT06128876Aortic Stenosis
Medical University of Vienna
Observational
1,500
Göttingen
2020-01-01
Recruiting
Terumo Aortic Global Endovascular Registry
NCT04246463Abdominal Aortic Aneurysm, Thoracic Aortic Aneurysm, Surgery
Vascutek Ltd.
Observational
1,000
Augsburg, Berlin, Chemnitz, Freiburg im Breisgau, Göttingen, Lingen, Münster, Tübingen
2019-12-17
Recruiting
Anticoagulation for New-Onset Post-Operative Atrial Fibrillation After CABG
NCT04045665Atrial Fibrillation, Stroke, Bleeding
Icahn School of Medicine at Mount Sinai
Phase 3
3,200
Berlin, Göttingen, Jena, Bad Nauheim, Bad Neustadt an der Saale, Bad Oeynhausen, Bonn, Braunschweig
2019-12-13
Active, closed
Alnylam Pharmaceuticals
Phase 3
655
Frankfurt am Main, Leipzig, Essen, Göttingen, Heidelberg, Münster, Würzburg
2019-11-26
Active, closed
Bristol-Myers Squibb
Phase 3
790
München, Bonn, Buxtehude, Dresden, Essen, Gera, Göttingen, Hanover
2019-10-28
Active, closed
Biogen
Phase 3
152
Freiburg im Breisgau, Göttingen, Bochum, Berlin
2019-10-18
Recruiting
Dr. Rebecca Schule
Observational
2,000
Bonn, Erlangen, Essen, Göttingen, Heidelberg, Lübeck, Magdeburg, München
2019-10-14
Recruiting
Stroke Thrombectomy and Aneurysm Registry
NCT04994756Stroke, Thromboses, Intracranial, Aneurysm, Brain
Medical University of South Carolina
Observational
40,000
Göttingen, Magdeburg
2019-09-17
Active, closed
MiCLASP Post Market Clinical Follow-Up (PMCF) Study
NCT04430075Mitral Regurgitation, Mitral Insufficiency
Edwards Lifesciences
Observational
1,000
Bad Krozingen, Tübingen, Ulm, Erlangen, München, Bernau bei Berlin, Giessen, Göttingen
2019-08-23
Active, closed
Edwards Lifesciences
Observational
150
Ulm, Bad Oeynhausen, Cologne, Berlin, Bonn, Dresden, Erlangen, Göttingen
2019-07-24
Recruiting
Surgimab
Phase 3
300
Göttingen
2019-06-17
Active, closed
AstraZeneca
Phase 3
724
Dresden, Göttingen, Halle, Hanover, Heidelberg, Homburg, Regensburg, Trier
2019-03-06
Active, closed
The European Robotic Spinal Instrumentation (EUROSPIN) Study
NCT03398915Degenerative Disc Disease, Spondylolisthesis, Spinal Stenosis, Recurrent Disc Herniation
Marc Schröder
Observational
932
Dortmund, Göttingen, Munich
2019-01-01
Recruiting
GISAR German Interdisciplinary Sarcoma Registry
NCT04122872Sarcoma, Sarcoma,Soft Tissue, Sarcoma of Bone, Carcinosarcoma
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest
Observational
9,000
Tübingen, Erlangen, Bad Saarow, Berlin, Berlin-Spandau, Frankfurt, Freiburg im Breisgau, Göttingen
2018-11-29
Active, closed
MB-CART19.1 r/r CD19+ B-cell Malignancies (BCM)
NCT03853616Acute Lymphoblastic Leukemia Recurrent, B-cell Lymphoma Recurrent, B-cell Lymphoma Refractory, Chronic Lymphocytic Leukemia Recurrent
DrugMB-CART19.1
Miltenyi Biomedicine GmbH
Phase 1
48
Berlin, Erlangen, Göttingen, Munich, Münster, Tübingen, Würzburg
2018-11-26
Active, closed
Obinutuzumab in Marginal Zone Lymphoma
NCT03322865Marginal Zone Lymphoma
DrugObinutuzumab
Christian Buske
Phase 2
56
Bochum, Essen, Freiburg im Breisgau, Göttingen, Halle, Koblenz, Mainz, Mannheim
2018-11-23
Active, closed
AstraZeneca
Phase 3
1,063
Bergisch Gladbach, Bonn, Cologne, Erlangen, Göttingen, Herne, Jena, Magdeburg
2018-11-16
Active, closed
Janssen Research & Development, LLC
Phase 3
629
Berlin, Braunschweig, Dresden, Düsseldorf, Erlangen, Frankfurt, Freiburg im Breisgau, Göttingen
2018-03-23
Recruiting
Randomization of Single vs Multiple Arterial Grafts
NCT03217006Coronary Artery Disease, Heart Diseases
Weill Medical College of Cornell University
Not applicable
4,300
Duisburg, Düsseldorf, Erlangen, Giessen, Göttingen, Jena, Leipzig, Oeynhausen
2018-01-07
Recruiting
LivaNova
Observational
500
Bamberg, Bonn, Cologne, Essen, Frankfurt, Freiburg im Breisgau, Göttingen, Hanover
2017-12-14
Active, closed
Tepotinib Phase II in NSCLC Harboring MET Alterations (VISION)
NCT02864992Advanced (Stage IIIB/IV) Non-small Cell Lung Cancer (NSCLC) With MET Exon 14 (METex14) Skipping Alterations or MET Amplification, Lung Adenocarcinoma Stage IIIB/IV
DrugTepotinib
EMD Serono Research & Development Institute, Inc.
Phase 2
337
Leipzig, Berlin, Chemnitz, Dresden, Erfurt, Gauting, Gera, Göttingen
2016-09-13
Active, closed
Tesaro, Inc.
Phase 3
733
Aachen, Berlin, Essen, Fürth, Göttingen, Heidelberg, Hildesheim, Mannheim
2016-07-11
Active, closed
Hoffmann-La Roche
Phase 2
534
Berlin, Cologne, Göttingen, Heidelberg
2015-11-19
Active, closed
Janssen Research & Development, LLC
Phase 2
239
Berlin, Erlangen, Essen, Freiburg im Breisgau, Göttingen, Greifswald, Hamburg, Hanover
2015-04-22
Recruiting
C-Brace Prospective Registry
NCT04640584Pareses, Lower Extremity
Otto Bock Healthcare Products GmbH
Observational
250
Traunstein, Göttingen, Hanover, Koblenz
2015-04
Active, closed
TransitionCHF Systolic Dysfunction to Congestive Heart Failure Cohort Study
NCT02323750Systolic Dysfunction, Transition, Heart Failure, Biobank
University of Göttingen
Observational
1,000
Göttingen
2014-12-01
Active, closed
Prevention of Symptomatic Skeletal Events With Denosumab Administered Every 4 Weeks Versus Every 12 Weeks
NCT02051218Metastatic Breast Cancer, Metastatic Prostate Cancer, Bone Metastases
DrugsReduced·Xgeva·Denosumab
Swiss Cancer Institute
Phase 3
1,380
Düsseldorf, Göttingen, Lübeck, Ulm
2014-07-16
Recruiting
Western Sydney Local Health District
Not applicable
1,058
Bad Neustadt an der Saale, Brandenburg, Göttingen, Leipzig
2014-02-27
Active, closed
Novartis Pharmaceuticals
Phase 3
240
Freiburg im Breisgau, Göttingen, Dresden, Bochum, Erlangen
2013-07-26
Active, closed
Neural Cardiac Therapy for Heart Failure Study (NECTAR-HF)
NCT01385176Heart Failure, Congestive Heart Failure
Boston Scientific Corporation
Not applicable
118
Bernau bei Berlin, Göttingen, Hamburg, Leipzig
2011-09-21
Active, closed
CVRx, Inc.
Not applicable
40
Cologn, Düsseldorf, Göttingen, Hanover, Leipzig
2011-06
Active, closed
Observational Study on Determinants of Dementia After Stroke
NCT01334749Ischemic Stroke, Hemorrhagic Stroke
Ludwig-Maximilians - University of Munich
Observational
736
Munich, Berlin, Bonn, Göttingen, Magdeburg
2011-04
Recruiting
Alport Therapy Registry - European Initiative Towards Delaying Renal Failure in Alport Syndrome
NCT02378805Alport Syndrome, Hereditary Kidney Disease, Pediatric Kidney Disease, Thin Basement Membrane Disease
DrugsSpironolactone·Finerenone
University Hospital Goettingen
Observational
800
Göttingen
1995-07
Rows per page Showing 1–200 of 200
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a German investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 20 October 2026. https://priyalifescience.com/clinical-trials-germany/city/g-ttingen

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Germany and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 5,062 studies in total at the last sync on 20 Oct 2026, 03:18 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 200 of those studies with a site in Göttingen.

How many clinical trials are recruiting in Göttingen?

106 of the 200 studies on this page are recruiting new participants as of the 20 Oct 2026, 03:18 UTC sync. A further 6 have not yet opened recruitment, 82 are active but closed to new participants, and 6 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Göttingen), 200 studies
PhaseStudiesRecruitingShare
Phase 3793339.5%
Observational513525.5%
Phase 2311515.5%
Not applicable211310.5%
Phase 1633%
Phase 1/2532.5%
Phase 2/3532.5%
Early Phase 1110.5%
Phase 4100.5%

Most active sponsors

Lead sponsors with the most studies (Göttingen)
Lead sponsorStudiesRecruiting
University Medical Center Goettingen1915
AstraZeneca127
argenx84
Institut für Klinische Krebsforschung IKF GmbH at Krankenhaus Nordwest74
Novartis Pharmaceuticals70
Hoffmann-La Roche62
Merck Sharp & Dohme LLC62
Incyte Corporation50
Ionis Pharmaceuticals, Inc.43
Janssen Research & Development, LLC42
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.